Benzinga | Aug 5, 2020 04:05PM EDT

OptimizeRx Q2 EPS $0.02 Beats $(0.03) Estimate, Sales $8.78M Beat $7.97M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 166.67 percent. This is a 77.78 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $8.78 million which beat the analyst consensus estimate of $7.97 million by 10.20 percent. This is a 25.36 percent increase over sales of $7.01 million the same period last year.